I am currently working for Pfizer in Collegeville, PA as a product technology specialist/strategist in the application engineering group within digital marketing. I am responsible for integrating various systems involved with channel and analytics data, campaign management, user preferences, etc. using MuleSoft and other technologies. I also support groups developing websites in PHP and Drupal, and have been known to lend a hand to the groups developing native mobile applications.
Before than I was a Senior Enterprise Architect for Cytel Inc. in Chesterbrook, PA, and before that I was a software engineer and architect for Wyeth and Pfizer in Collegeville, PA. I concentrate on designing and building enterprise software in Java, .NET, and related technologies to support clinical trial design and execution with a strong focus in adaptive trials. I am a strong advocate of the Feature Driven Development (FDD) process, Modeling in Color, and Peer Code Review.
I have been developing software since 1995 in Java, C#, Visual Basic, ASP, PHP, and C. My primary focus has been designing and developing web-based applications, although I have worked on my share of client applications, web services, and PL/SQL. I also do freelance web development in my spare time.
In additional to my Java, PHP, and C# background, I also have worked with Python and Ruby.
I live in Birdsboro, a small town near Reading, PA with my two children. I was born in Las Vegas, NV, and raised in Alamogordo, NM before coming to the Philadelphia area in 1997. I enjoy living in the northeast, but I do miss the sunsets, mild winters, and the mountains of the southwest.
I enjoy the outdoors, sports, woodworking, photography, space and spending time with my children. I also enjoy recreational math, crossword puzzles, beer, wine (mainly pinot noir and chardonnay), movies, and collecting Scouting patches, matchbooks and foreign coins. I enjoy watching and playing all sports and support the Green Bay Packers, Chelsea FC, New York Rangers, and Philadelphia Phillies.
Last updated: January 1, 2019